stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
X 4 Pharmaceuticals IncXFOR
$3.350.30%-0.010
Dopo l'orario di chiusura: 3.350.00 0.00%

X 4 Pharmaceuticals Inc (XFOR)

Date: 2026-10-30 16:00O: 3.33H: 3.41L: 3.19C: 3.35Vol: 706.2k
Precedente Chiudi:
$3.36
Aprire:
$3.33
Volume 24 ore:
706,226
Volume relativo:
0.98
Capitalizzazione di mercato:
$332.14M
Reddito:
$9.01M
Utile/perdita netta:
-$99.72M
Rapporto P/E:
-
EPS:
-$4.54
Flusso di cassa netto:
-$92.85M
1W Prestazione:
+3.40%
1M Prestazione:
+15.52%
6M Prestazione:
-17.69%
1Y Prestazione:
-16.04%
Intervallo 1D:
$3.19$3.41
Intervallo di 1 settimana:
$3.05$3.49
Portata 52W:
$2.43$4.83

Profilo aziendale di X 4 Pharmaceuticals Inc (XFOR)

Nome
X 4 Pharmaceuticals Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
857-529-8300
Indirizzo
61 NORTH BEACON STREET, BOSTON, MA, USA
Dipendente
45
Prossima data di guadagno
2026-11-04
Ultimi documenti SEC
SEC
Discussioni di XFOR su X
X

Confronta XFOR con VRTX, REGN, MRNA, ARGX, ONC

AzioniPrezzoCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
XFOR
X 4 Pharmaceuticals Inc
$3.35$332.14M$9.01M-$99.72M-$92.85M-$4.54
VRTX
Vertex Pharmaceuticals Inc
$558.88$141.65B$12.34B$4.34B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$927.89$95.53B$14.92B$4.42B$3.79B$41.04
MRNA
Moderna Inc
$221.72$88.52B$2.23B-$3.19B-$1.60B-$8.15
ARGX
Argen X Se Adr
$892.87$56.15B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$370.33$41.89B$5.76B$514.49M$1.10B$4.48

X 4 Pharmaceuticals Inc Azioni (XFOR) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-07-10IniziatoWells FargoOverweight
2026-06-02IniziatoLeerink PartnersOutperform
2026-03-09IniziatoGuggenheimBuy
2025-12-05ResumedStifelBuy

X 4 Pharmaceuticals Inc Azioni (XFOR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

X 4 Pharmaceuticals Inc Azioni (XFOR) insider trading

  • David KirskeOct 01 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $2.86
    #Azioni
    11,767
    Valore ($)
    33,658
    #Azioni Totale
    0
  • KIRSKE DAVIDOct 01 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $2.86
    #Azioni
    11,767
    Valore ($)
    33,658
    #Azioni Totale
    155,983
  • Craig Adam RAug 12 '26
    Executive Chairman
    Transazione
    Sale
    Costo
    $4.44
    #Azioni
    47,436
    Valore ($)
    210,829
    #Azioni Totale
    328,651
  • Volpone JohnAug 12 '26
    President
    Transazione
    Sale
    Costo
    $4.44
    #Azioni
    24,576
    Valore ($)
    109,228
    #Azioni Totale
    265,305
  • John VolponeAug 12 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $4.55
    #Azioni
    24,576
    Valore ($)
    111,944
    #Azioni Totale
    0
  • Adam CraigAug 12 '26
    Executive Chaiman
    Transazione
    Proposed Sale
    Costo
    $4.56
    #Azioni
    47,436
    Valore ($)
    216,071
    #Azioni Totale
    0
  • KIRSKE DAVIDJun 30 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $4.26
    #Azioni
    8,543
    Valore ($)
    36,428
    #Azioni Totale
    167,750
  • David KirskeMay 12 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $4.29
    #Azioni
    16,961
    Valore ($)
    72,820
    #Azioni Totale
    0
  • KIRSKE DAVIDMay 12 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $4.29
    #Azioni
    16,961
    Valore ($)
    72,820
    #Azioni Totale
    176,293
  • Craig Adam ROct 23 '25
    Executive Chairman
    Transazione
    Buy
    Costo
    $2.90
    #Azioni
    86,206
    Valore ($)
    249,997
    #Azioni Totale
    376,087
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
David KirskeOfficerOct 01 '26Proposed Sale$2.8611,76733,6580
KIRSKE DAVIDChief Financial OfficerOct 01 '26Sale$2.8611,76733,658155,983
Craig Adam RExecutive ChairmanAug 12 '26Sale$4.4447,436210,829328,651
Volpone JohnPresidentAug 12 '26Sale$4.4424,576109,228265,305
John VolponeOfficerAug 12 '26Proposed Sale$4.5524,576111,9440
Adam CraigExecutive ChaimanAug 12 '26Proposed Sale$4.5647,436216,0710
KIRSKE DAVIDChief Financial OfficerJun 30 '26Sale$4.268,54336,428167,750
David KirskeOfficerMay 12 '26Proposed Sale$4.2916,96172,8200
KIRSKE DAVIDChief Financial OfficerMay 12 '26Sale$4.2916,96172,820176,293
Craig Adam RExecutive ChairmanOct 23 '25Buy$2.9086,206249,997376,087

X 4 Pharmaceuticals Inc Borsa (XFOR) Ultime notizie

Oct 28, 2026
Oct 28, 2026
Oct 20, 2026
Oct 20, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 09, 2026
Oct 09, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 07, 2026
Oct 07, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Aug 19, 2018
Aug 19, 2018
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 05, 2026
Sep 05, 2026
Sep 05, 2026
Sep 05, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 01, 2026
Sep 01, 2026

Simile a XFOR